Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies

Bowman, Robert L., Busque, Lambert, Levine, Ross L.·2018·Cell stem cell

Cited by (454)

Items 101–200 of 454

  1. Full Spectrum of Clonal Haematopoiesis-Driver Mutations in Chronic Heart Failure and their Associations with Mortality
    Katharina C. Kiefer, Sebastian Cremer, Evangelia Pardali, Birgit Aßmus, Khalil Abou‐El‐Ardat, Klara Kirschbaum, Lena Dorsheimer, Tina Rasper, Alexander Berkowitsch, Hubert L. Serve et al. · 2021 · ESC Heart Failure
  2. Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis
    Hanneke C. Kluin‐Nelemans, Mohamad Jawhar, Andreas Reiter, Björn van Anrooij, Jason R. Gotlib, Karin Hartmann, Anja Illerhaus, Hanneke N.G. Oude Elberink, Aleksandra Górska, Marek Niedoszytko et al. · 2020 · Theranostics
  3. Lamin B1 deletion in myeloid neoplasms causes nuclear anomaly and altered hematopoietic stem cell function
    Andreea Reilly, John Philip Creamer, Sintra Stewart, Massiel Chavez Stolla, Yuchuan Wang, Jing Du, Rachel Wellington, Stephanie Busch, Elihu H. Estey, Pamela Sue Becker et al. · 2022 · Cell stem cell
  4. Next Generation Sequencing in MPNs. Lessons from the Past and Prospects for Use as Predictors of Prognosis and Treatment Responses
    Vibe Skov · 2020 · Cancers
  5. Hematopoietic Stem Cells and Their Niche in Bone Marrow
    Munju Kwon, Byoung Soo Kim, Sik Yoon, Sae‐Ock Oh, Dongjun Lee · 2024 · International Journal of Molecular Sciences
  6. Mitochondrial Control of Genomic Instability in Cancer
    Massimo Bonora, Sonia Missiroli, Mariasole Perrone, Francesco Fiorica, Paolo Pinton, Carlotta Giorgi · 2021 · Cancers
  7. A macaque clonal hematopoiesis model demonstrates expansion of TET2-disrupted clones and utility for testing interventions
    Tae–Hoon Shin, Yifan Zhou, Shirley Chen, Stefan Cordes, Max Z. Grice, Xing Fan, Byung‐Chul Lee, Aisha A. Aljanahi, So Gun Hong, Kelli L. Vaughan et al. · 2022 · Blood
  8. Next generation sequencing for liquid biopsy based testing in non-small cell lung cancer in 2021
    Pasquale Pisapia, José Luís Costa, Francesco Pepe, Gianluca Russo, Gianluca Gragnano, Alessandro Russo, Antonino Iaccarino, Diego de Miguel‐Pérez, María José Serrano, Valeria Cecilia Denninghoff et al. · 2021 · Critical Reviews in Oncology/Hematology
  9. Emerging Therapies for Acute Myelogenus Leukemia Patients Targeting Apoptosis and Mitochondrial Metabolism
    Germana Castelli, Elvira Pelosi, Ugo Testa · 2019 · Cancers
  10. The chromatin-binding protein Phf6 restricts the self-renewal of hematopoietic stem cells
    Satoru Miyagi, Patrycja Sroczyńska, Yuko Kato, Yaeko Nakajima‐Takagi, Motohiko Oshima, Ola Rizq, Naoya Takayama, Atsunori Saraya, Seiya Mizuno, Fumihiro Sugiyama et al. · 2019 · Blood
  11. Single-cell genomics identifies distinct B1 cell developmental pathways and reveals aging-related changes in the B-cell receptor repertoire
    Yao Luo, Jing Wang, Kairui Li, Mingxia Li, Shasha Xu, Xingjie Liu, Zhiwei Zhang, Xiang Ming Xu, Yu Zhang, Jiawei Pan et al. · 2022 · Cell & Bioscience
  12. STING activation in TET2-mutated hematopoietic stem/progenitor cells contributes to the increased self-renewal and neoplastic transformation
    Jiaying Xie, Mengyao Sheng, Shaoqin Rong, Dan Zhou, Chao Wang, Wanling Wu, Jingru Huang, Yue Sun, Yin Wang, Pingyue Chen et al. · 2023 · Leukemia
  13. From clonal hematopoiesis to myeloid leukemia and what happens in between: Will improved understanding lead to new therapeutic and preventive opportunities?
    Jan Philipp Bewersdorf, Anastasia Ardasheva, Nikolai Alexandrovich Podoltsev, Abhay Singh, Giulia Biancon, Stephanie Halene, Amer Methqal Zeidan · 2019 · Blood Reviews
  14. SHP2 inhibition reduces leukemogenesis in models of combined genetic and epigenetic mutations
    Ruchi Pandey, Baskar Ramdas, Changlin Wan, George Earl Sandusky, Morvarid Mohseni, Chi Zhang, Reuben Kapur · 2019 · Journal of Clinical Investigation
  15. The Clinical Challenge of Idiopathic Cytopenias of Undetermined Significance (ICUS) and Clonal Cytopenias of Undetermined Significance (CCUS)
    David P. Steensma · 2019 · Current Hematologic Malignancy Reports
  16. The Akt–mTOR network at the interface of hematopoietic stem cell homeostasis
    Feng Wu, Zhe Chen, Jingbo Liu, Yu Hou · 2021 · Experimental Hematology
  17. Circles of Life: linking metabolic and epigenetic cycles to immunity
    Chan‐Wang Jerry Lio, Stanley Ching‐Cheng Huang · 2020 · Immunology
  18. Targeting Immunophenotypic Markers on Leukemic Stem Cells: How Lessons from Current Approaches and Advances in the Leukemia Stem Cell (LSC) Model Can Inform Better Strategies for Treating Acute Myeloid Leukemia (AML)
    Kelly Mitchell, Ulrich G. Steidl · 2019 · Cold Spring Harbor Perspectives in Medicine
  19. Recent advances of nanodrug delivery system in the treatment of hematologic malignancies
    Qian-Ling Ye, Yun Hsuan Lin, Ruihao Li, Huaiji Wang, Chunyan Dong · 2022 · Seminars in Cancer Biology
  20. The sculpting of somatic mutational landscapes by evolutionary forces and their impacts on aging‐related disease
    Fabio Marongiu, James V. DeGregori · 2022 · Molecular Oncology
  21. The ClinGen Brain Malformation Variant Curation Expert Panel: Rules for somatic variants in AKT3, MTOR, PIK3CA, and PIK3R2
    Abbe Lai, Aubrie Soucy, Christelle Moufawad El Achkar, A. James Barkovich, Yang Cao, Marina T. DiStefano, Michael J. Evenson, Renzo Guerrini, Devon Knight, Yi-Shan Lee et al. · 2022 · Genetics in Medicine
  22. DNA damage accumulation and repair defects in FLT3‐ITD acute myeloid leukemia: Implications for clonal evolution and disease progression
    Francisco Alejandro Lagunas‐Rangel · 2022 · Hematological Oncology
  23. Clonal Hematopoiesis and risk of Acute Myeloid Leukemia
    Pinkal M. Desai, Duane C. Hassane, Gail J. Roboz · 2019 · Best Practice & Research Clinical Haematology
  24. Insights into clonal hematopoiesis and its relation to cancer risk
    Shaneice Renee Mitchell, Jayakrishnan Gopakumar, Siddhartha Jaiswal · 2021 · Current Opinion in Genetics & Development
  25. Clonal Hematopoiesis: Updates and Implications at the Solid Tumor-Immune Interface
    Marco M. Buttigieg, Michael J. Rauh · 2023 · JCO Precision Oncology
  26. Decoding leukemia at the single-cell level: clonal architecture, classification, microenvironment, and drug resistance
    Jianche Liu, Penglei Jiang, Zezhen Lu, Zebin Yu, Pengxu Qian · 2024 · Experimental Hematology and Oncology
  27. Cadmium Activates Noncanonical Wnt Signaling to Impair Hematopoietic Stem Cell Function in Mice
    Yifan Zhao, Qian Li, Zhengli Yang, Yiming Shao, Peng Xue, Weidong Qu, Xiaodong Jia, Longzhen Cheng, Miao He, Rui He et al. · 2018 · Toxicological Sciences
  28. Molecular Minimal Residual Disease in Acute Myeloid Leukemia
    Laurent Mauvieux, Laurent Miguet, Luc‐Matthieu Fornecker · 2018 · New England Journal of Medicine
  29. Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer
    Yang Feng, Qingchen Yuan, Rachel C. Newsome, Troy M. Robinson, Robert L. Bowman, Ashley N. Zuniga, Kendra N. Hall, Cassandra M. Bernsten, Daniil E. Shabashvili, Kathryn I. Krajcik et al. · 2023 · The Journal of Experimental Medicine
  30. Evaluating Clonal Hematopoiesis in Tumor-Infiltrating Leukocytes in Breast Cancer and Secondary Hematologic Malignancies
    Elizabeth Anne Comen, Robert L. Bowman, Pier Selenica, Maria Kleppe, Noushin Rahnamay Farnoud, Fresia G. Pareja, Britta Weigelt, Corinne E. Hill, Abigail Alon, Felipe Correa Geyer et al. · 2019 · JNCI Journal of the National Cancer Institute
  31. Aging and leukemic evolution of hematopoietic stem cells under various stress conditions
    Shuhei Kurosawa, Atsushi Iwama · 2020 · Inflammation and Regeneration
  32. Clonal Hematopoiesis and Mutations of Myeloproliferative Neoplasms
    Lasse Kjær · 2020 · Cancers
  33. Loss of a 7q gene,CUX1, disrupts epigenetically driven DNA repair and drives therapy-related myeloid neoplasms
    Molly K. Imgruet, Julian Lutze, Ningfei An, Bonnie Y. Hu, Saira Saeed Khan, Jeffrey L. Kurkewich, Tanner C. Martinez, Donald J. Wolfgeher, Sandeep K. Gurbuxani, Stephen J. Kron et al. · 2021 · Blood
  34. Molecular Landscape of Therapy-related Myeloid Neoplasms in Patients Previously Treated for Gynecologic and Breast Cancers
    Sabine Khalife‐Hachem, Khalil Saleh, Florence Pasquier, Christophe Willekens, Anthony Tarabay, Leony Antoun, Thomas Grinda, Cristina Castilla‐Llorente, Matthieu Duchmann, Cyril Quivoron et al. · 2021 · HemaSphere
  35. Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content
    Devika Ganesamoorthy, Alan J. Robertson, Wenhan Chen, Michael B. Hall, Minh Duc Cao, Kaltin Ferguson, Sunil R. Lakhani, Kátia Nones, Peter T. Simpson, Lachlan Coin · 2022 · BMC Cancer
  36. Association of clonal hematopoiesis mutations with clinical outcomes: A systematic review and meta‐analysis
    Malgorzata Klaudia Nowakowska, Taebeom Kim, Mikayla T. Thompson, Kelly L. Bolton, Anita Deswal, Steven H. Lin, Paul Scheet, Mackenzie R. Wehner, Kevin Thomas Nead · 2022 · American Journal of Hematology
  37. Clonal Hematopoiesis and therapy related MDS/AML
    Pinkal M. Desai, Gail J. Roboz · 2019 · Best Practice & Research Clinical Haematology
  38. Response to Rucaparib in BRCA-Mutant Metastatic Castration-Resistant Prostate Cancer Identified by Genomic Testing in the TRITON2 Study
    Andrea Loehr, Akash Patnaik, David Colin Campbell, Jeremy David Shapiro, Alan Haruo Bryce, Ray McDermott, Brieuc R. Sautois, Nicholas J. Vogelzang, Richard Martin Bambury, Éric Voog et al. · 2021 · Clinical Cancer Research
  39. Distinct and opposite effects of leukemogenic Idh and Tet2 mutations in hematopoietic stem and progenitor cells
    Jérôme Fortin, Ming-Feng Chiang, Cem Meydan, Jonathan Foox, Parameswaran Ramachandran, Julie Leca, François Lemonnier, Wanda Y. Li, Miki S. Gams, Takashi Sakamoto et al. · 2023 · Proceedings of the National Academy of Sciences
  40. Somatic mutations and T-cell clonality in patients with immunodeficiency
    Paula Savola, Timi Martelius, Matti Kankainen, Jani Huuhtanen, Sofie Lundgren, Yrjö Koski, Samuli Eldfors, Tiina Kelkka, Mikko A. I. Keränen, Pekka Ellonen et al. · 2019 · Haematologica
  41. Mitochondria-enriched hematopoietic stem cells exhibit elevated self-renewal capabilities, thriving within the context of aged bone marrow
    Haruhito Totani, Takayoshi Matsumura, Rui Yokomori, Terumasa Umemoto, Yuji Takihara, Chong Yang, Lee Hui Chua, Atsushi Watanabe, Takaomi Sanda, Toshio Suda · 2025 · Nature Aging
  42. Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes and in Acute Myeloid Leukemias
    Ugo Testa, Germana Castelli, Elvira Pelosi · 2020 · Cancers
  43. Inherited blood cancer predisposition through altered transcription elongation
    Jiawei Zhao, Liam D. Cato, Uma P. Arora, Erik L. Bao, Samuel C. Bryant, Nicholas Williams, Yuemeng Jia, Seth Raphael Goldman, Jyoti Nangalia, Michael A. Erb et al. · 2024 · Cell
  44. Hematopoietic Stem Cells Self-Renew Symmetrically or Gradually Proceed to Differentiation
    Melania Barile, Katrin Busch, Ann-Kathrin Fanti, Alessandro Greco, Xi Wang, Hideyuki Oguro, Qin Zhang, Sean J. Morrison, Hans-Reimer Rodewald, Thomas Höfer · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  45. BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients
    Alex Friedlaender, Aurélie Vuilleumier, Valeria Viassolo, Aurélie Ayme, Solène De Talhouet, Jean‐Damien Combes, Julien Péron, Alexandre Bodmer, Sophie Giraud, Adrien Buisson et al. · 2019 · Breast Cancer Research and Treatment
  46. Hematopoietic alterations in chronic heart failure patients by somatic mutations leading to clonal hematopoiesis
    Lena Dorsheimer, Birgit Aßmus, Tina Rasper, Christina A. Ortmann, Khalil Abou‐El‐Ardat, Katharina C. Kiefer, Jedrzej Hoffmann, Florian Hartmut Seeger, Halvard B. Bonig, Stefanie Dimmeler et al. · 2019 · Haematologica
  47. Colony Stimulating Factor 1 Receptor in Acute Myeloid Leukemia
    Kristine Yttersian Sletta, Oriol Castells, Bjørn Tore Gjertsen · 2021 · Frontiers in Oncology
  48. Resistance to Hypomethylating Agents in Myelodysplastic Syndrome and Acute Myeloid Leukemia From Clinical Data and Molecular Mechanism
    Guangjie Zhao, Qian Wang, S. Li, Xiaoqin Wang · 2021 · Frontiers in Oncology
  49. Novel Markers for Liquid Biopsies in Cancer Management: Circulating Platelets and Extracellular Vesicles
    Sara Corvigno, Anna Maria Johnson, Kwong‐Kwok Wong, Min Soon Cho, Vahid Afshar‐Kharghan, David G. Menter, Anil K. Sood · 2022 · Molecular Cancer Therapeutics
  50. Inherited Causes of Clonal Hematopoiesis of Indeterminate Potential in TOPMed Whole Genomes
    Alexander G. Bick, Joshua S. Weinstock, Satish Kumar Nandakumar, Charles P. Fulco, Matthew Joseph Leventhal, Erik L. Bao, Joseph Nasser, Seyedeh Maryam Zekavat, Mindy D Szeto, Cecelia A. Laurie et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  51. Minimal Residual Disease Detection: Implications for Clinical Diagnosis and Cancer Patient Treatment
    Meiling Song, Wenjing Pan, Xinjie Yu, Jie Ren, Congli Tang, Zhu Chen, Zhe Wang, Yan Deng, Nongyue He, Hongna Liu et al. · 2025 · MedComm
  52. Clonal hematopoiesis with DNMT3A and PPM1D mutations impairs regeneration in autologous stem cell transplant recipients
    Patrick Stelmach, Sarah Richter, Sandra Sauer, Margarete A. Fabre, Muxin Gu, Christian Rohde, Maike Janssen, Nora Liebers, Rumyana Proynova, Niels Weinhold et al. · 2023 · Haematologica
  53. Clonal hematopoiesis of indeterminate potential and its impact on patient trajectories after stem cell transplantation
    Derek S. Park, Afua Adutwumwa Akuffo, David E. Muench, H. Leighton Grimes, Pearlie K. Epling‐Burnette, Philip K. Maini, Alexander R.A. Anderson, Michael B. Bonsall · 2019 · PLoS Computational Biology
  54. Clonal hematopoiesis driven by somatic mutations: A new player in atherosclerotic cardiovascular disease
    Marta Amorós-Pérez, José J. Fuster · 2020 · Atherosclerosis
  55. Sex-Related Differences in Chronic Myeloid Neoplasms: From the Clinical Observation to the Underlying Biology
    Theodoros Karantanos, Tania Jain, Alison R. Moliterno, Richard John Jones, Amy Elizabeth Dezern · 2021 · International Journal of Molecular Sciences
  56. Cell-type-specific consequences of mosaic structural variants in hematopoietic stem and progenitor cells
    Karen Grimes, Hyobin Jeong, Amanda Amoah, Nuo Xu, Julian Niemann, Benjamin Raeder, Patrick Hasenfeld, Catherine Stober, Tobias Rausch, Eva Benito et al. · 2024 · Nature Genetics
  57. Loss of Kmt2c or Kmt2d primes urothelium for tumorigenesis and redistributes KMT2A–menin to bivalent promoters
    Naitao Wang, Mohini R. Pachai, Dan Li, Cindy J. Lee, Sarah Warda, Makhzuna N. Khudoynazarova, Woo Hyun Cho, Guojia Xie, Sagar R Shah, Yao Li et al. · 2025 · Nature Genetics
  58. Clonal expansion dictates the efficacy of mitochondrial lineage tracing in single cells
    Xin Wang, Kun Wang, Weixing Zhang, Zhongjie Tang, Hao Zhang, Yuying Cheng, Da Zhou, Chao Zhang, Wen‐Zhao Zhong, Qing Ma et al. · 2025 · Genome biology
  59. Protein phosphatase, Mg2+/Mn2+‐dependent 1D (PPM1D) mutations in haematological cancer
    Simon Husby, Emma Hjermind Justesen, Kirsten Grønbæk · 2020 · British Journal of Haematology
  60. ID2 and HIF-1α collaborate to protect quiescent hematopoietic stem cells from activation, differentiation, and exhaustion
    Brad L. Jakubison, Tanmoy Sarkar, Kristbjorn O. Gudmundsson, Shweta Singh, Lei Sun, Holly M. Morris, Kimberly D. Klarmann, Jonathan R. Keller · 2022 · Journal of Clinical Investigation
  61. Single-cell methods in myeloproliferative neoplasms: old questions, new technologies
    Jennifer O’Sullivan, Adam J. Mead, Bethan Psaila · 2022 · Blood
  62. Measurable Residual Disease Detection in Acute Myeloid Leukemia: Current Challenges and Future Directions
    Jennifer M. Moritz, Antonia Schwab, Andreas Reinisch, Armin Zebisch, Heinz Sill, Albert Wölfler · 2024 · Biomedicines
  63. Detection of Circulating Tumor DNA in Liquid Biopsy: Current Techniques and Potential Applications in Melanoma
    Clara Martínez-Vila, Cristina Teixidó, Francisco Aya, Roberto Martín, Europa Azucena González‐Navarro, Llúcia Alós, Natalia Castrejón de Anta, Ana Maria Arance · 2025 · International Journal of Molecular Sciences
  64. Recent technologies enhancing the clinical utility of circulating tumor DNA
    Aarthi Manoharan, Sambandam Ravikumar, Vishnu Ballambattu Bhat · 2020 · Clinica Chimica Acta
  65. In vivo genome-wide CRISPR screening in murine acute myeloid leukemia uncovers microenvironmental dependencies
    F. Mercier, Jian-Tao Shi, D. Sykes, T. Oki, M. Jankovic, C. Man, Y. Kfoury, Elizabeth Miller, Shu-Tao He, A. Zhu et al. · 2022 · Blood Advances
  66. Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendations
    Abhishek Avinash Mangaonkar, Mrinal M. Patnaik · 2023 · American Journal of Hematology
  67. Blood‐based circulating tumor DNA mutations as a diagnostic and prognostic biomarker for lung cancer
    Maria Leung, Maxim B. Freidin, Maxim Freydin, C. Von Crease, Paulo De Sousa, Monica T. Barbosa, Andrew Gordon Nicholson, Eric Kian Saik Lim · 2020 · Cancer
  68. From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression
    Carmelo Gurnari, Emiliano Fabiani, Giulia Falconi, Serena Travaglini, Tiziana Ottone, Antonio Cristiano, Maria Teresa Voso · 2021 · Biology
  69. Differential H4K16ac levels ensure a balance between quiescence and activation in hematopoietic stem cells
    Cecília Pessoa Rodrigues, Asifa Akhtar · 2021 · Science Advances
  70. Comprehensive landscape and interference of clonal haematopoiesis mutations for liquid biopsy: A Chinese pan‐cancer cohort
    Enwu Xu, Kai Su, Yang Zhou, Longlong Gong, Yiwen Xuan, Ming Liao, Jiawang Cao, Yaqian Li, Yujiao Lu, Yi Zhao et al. · 2021 · Journal of Cellular and Molecular Medicine
  71. Clonal Hematopoiesis and Premalignant Diseases
    Justin D. Kaner, Pinkal M. Desai, Nuria Mencia-Trinchant, Mónica L. Guzmán, Gail J. Roboz, Duane C. Hassane · 2019 · Cold Spring Harbor Perspectives in Medicine
  72. Joint representation and visualization of derailed cell states with Decipher
    Achille Nazaret, Joy Linyue Fan, Vincent‐Philippe Lavallée, Cassandra Burdziak, Andrew E. Cornish, Vaidotas Kiseliovas, Robert L. Bowman, Ignas Masilionis, Jaeyoung Chun, Shira Esther Eisman et al. · 2025 · Genome biology
  73. Stem cell mutations can be detected in myeloma patients years before onset of secondary leukemias
    Ashwin Sridharan, Carolina Schinke, George Ivanov Georgiev, Mariana da Silva Ferreira, Victor J. Thiruthuvanathan, Ian C. MacArthur, Tushar Damodar Bhagat, Gaurav S. Choudhary, Srinivas Aluri, Jiahao Chen et al. · 2019 · Blood Advances
  74. Modification of stem cell states by alcohol and acetaldehyde
    Ryan N. Serio, Lorraine J. Gudas · 2019 · Chemico-Biological Interactions
  75. Engineering human hematopoietic environments through ossicle and bioreactor technologies exploitation
    Pia Sommerkamp, François Mercier, Adam C. Wilkinson, Dominique A. Bonnet, Paul Emile Bourgine · 2020 · Experimental Hematology
  76. Molecular diagnosis of T-cell lymphoma: a correlative study of PCR-based T-cell clonality assessment and targeted NGS
    Charlotte Syrykh, Pauline Gorez, Sarah Péricart, David Grand, Fréderic Escudié, Bastien Cabarrou, Lucie Obéric, Loïc Ysebaert, Laurence Lamant, Camille Laurent et al. · 2021 · Blood Advances
  77. Single-Cell Epigenomics Reveals Mechanisms of Cancer Progression
    Lindsay M. LaFave, Rachel E. Savage, Jason D. Buenrostro · 2022 · Annual Review of Cancer Biology
  78. A fetal tumor suppressor axis abrogates MLL-fusion-driven acute myeloid leukemia
    Mohamed Eldeeb, Ouyang Yuan, Nicola Guzzi, Phuong Cao Thi Ngoc, Anna Konturek-Cieśla, Trine Ahn Kristiansen, Sowndarya Muthukumar, Jeffrey A. Magee, Cristian Bellodi, Joan Yuan et al. · 2023 · Cell Reports
  79. A View on Drug Development for Cancer Prevention
    Andrew R. Reynolds, Michele Moschetta, Alula R. Yohannes, Farzana L. Walcott, Marianne B. Ashford, Zoltán Szűcs, Tina Sarbajna, James Hadfield, Eden Harrison, Benjamin Challis et al. · 2023 · Cancer Discovery
  80. GTAC enables parallel genotyping of multiple genomic loci with chromatin accessibility profiling in single cells
    Sven Turkalj, Niels Asger Jakobsen, Angus Groom, Marlen Metzner, Simone G. Riva, Eran Gur, Batchimeg Usukhbayar, Mirian Angulo Salazar, Lance D. Hentges, Gerda Mickute et al. · 2023 · Cell stem cell
  81. Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
    Karina Barbosa, A. Deshpande · 2023 · Frontiers in Oncology
  82. Hematopoietic Stem Cell Heterogeneity
    Roland Jurecic · 2019 · Advances in experimental medicine and biology
  83. Dynamic clonal hematopoiesis and functional T-cell immunity in a supercentenarian
    Erik B. van den Akker, Stavros Makrodimitris, Marc Hulsman, Martijn H. Brugman, Tatjana Nikolić, Ted Bradley, Quinten Waisfisz, Frank Baas, Marja E. Jakobs, Daphne de Jong et al. · 2020 · Leukemia
  84. Loss of SIRT1 inhibits hematopoietic stem cell aging and age-dependent mixed phenotype acute leukemia
    Zhiqiang Wang, Chunxiao Zhang, Charles Warden, Zheng Liu, Yate‐Ching Yuan, Chao Guo, Charles Wang, Jinhui Wang, Xiwei Wu, Richard W. Ermel et al. · 2022 · Communications Biology
  85. Targeting stem cells in myelodysplastic syndromes and acute myeloid leukemia
    Petter S. Woll, Tetsuichi Yoshizato, Eva Hellström‐Lindberg, Thoas Fioretos, Benjamin L. Ebert, Sten Eirik W. Jacobsen · 2022 · Journal of Internal Medicine
  86. Advances in nano-immunotherapy for hematological malignancies
    Jian Xu, Wenqi Liu, Fengjuan Fan, Bo Zhang, Chunyan Sun, Yu Hu · 2024 · Experimental Hematology and Oncology
  87. Diagnostic molecular techniques in haematology: recent advances
    Aikaterini Koutsi, Elisavet‐Christina Vervesou · 2018 · Annals of Translational Medicine
  88. From the niche to malignant hematopoiesis and back: reciprocal interactions between leukemia and the bone marrow microenvironment
    Celia A. Soto, Cristina Lo Celso, Louise E. Purton, Benjamin J. Frisch · 2021 · JBMR Plus
  89. Engineered Tissue Models to Replicate Dynamic Interactions within the Hematopoietic Stem Cell Niche
    Aidan E. Gilchrist, Brendan A.C. Harley · 2021 · Advanced Healthcare Materials
  90. Somatic mutation panels: Time to clear their names
    Amy M. Trottier, Marcela Cavalcante de Andrade Silva, Zejuan Li, Lucy A. Godley · 2019 · Cancer Genetics
  91. Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasms
    Eline J.M. Bertrums, Jurrian K. de Kanter, Lucca L. M. Derks, Mark Verheul, Laurianne Trabut, Markus J. van Roosmalen, Henrik Hasle, Evangelia Antoniou, Dirk Reinhardt, Michael Norbert Dworzak et al. · 2024 · Nature Communications
  92. Mouse acute leukemia develops independent of self-renewal and differentiation potentials in hematopoietic stem and progenitor cells.
    Fang Dong, Hai-Tao Bai, Xiao-Fang Wang, Shan-Shan Zhang, Zhao Wang, Miner Xie, Sen Zhang, Jinhong Wang, Hao Sha, T. Cheng et al. · 2019 · Blood Advances
  93. Preleukemic and leukemic evolution at the stem cell level
    Jacob Stauber, John M. Greally, Ulrich G. Steidl · 2020 · Blood
  94. Inflammation and hematopoietic stem cells aging
    Hanqing He, Jianwei Wang · 2020 · Blood Science
  95. Clonal approaches to understanding the impact of mutations on hematologic disease development
    Jyoti Nangalia, Emily Mitchell, Anthony Richard Green · 2019 · Blood
  96. Life style factors, tumor cell plasticity and cancer stem cells
    Ilaria Chiodi, Chiara Mondello · 2020 · Mutation Research/Reviews in Mutation Research
  97. Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A
    Alexander M. Grandits, Rotraud Wieser · 2021 · Experimental Hematology
  98. Molecular Pathways in Clonal Hematopoiesis: From the Acquisition of Somatic Mutations to Transformation into Hematologic Neoplasm
    Charles Gaulin, Katalin Kelemen, Cecilia Arana Yi · 2022 · Life
  99. Clonal hematopoiesis in myeloid malignancies and solid tumors
    Xiurong Cai, Robert L. Bowman, Jennifer J. Trowbridge · 2025 · Nature Cancer
  100. Epigenetic and proteomic signatures associate with clonal hematopoiesis expansion rate
    Taralynn Mack, Michael A. Raddatz, Yash Pershad, Daniel C. Nachun, Kent D. Taylor, Xiuqing Guo, Alan R. Shuldiner, Jeffrey R. O’Connell, Eimear E. Kenny, Ruth J. F. Loos et al. · 2024 · Nature Aging